Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Free Cash Flow Generation Index
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Free Cash Flow Generation Index of -1.39x as of September 2025. Free cash flow of CN¥-87.60 Million represents -1% of operating cash flow (CN¥62.99 Million). Explore 600867 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tonghua Dongbao Pharmaceutical Co Ltd Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for Tonghua Dongbao Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see 600867 cash generation efficiency.
Annual Free Cash Flow Generation for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year Free Cash Flow Generation Index for Tonghua Dongbao Pharmaceutical Co Ltd. Check how aggressively does Tonghua Dongbao Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥171.53 Million | CN¥689.23 Million | CN¥517.69 Million | ▲ +205.0% |
| 2024 | -0.24x | CN¥-108.99 Million | CN¥459.74 Million | CN¥568.73 Million | ▼ -139.8% |
| 2023 | 0.60x | CN¥513.40 Million | CN¥861.52 Million | CN¥348.13 Million | ▲ +38.5% |
| 2022 | 0.43x | CN¥371.47 Million | CN¥863.09 Million | CN¥491.63 Million | ▼ -8.5% |
| 2021 | 0.47x | CN¥533.80 Million | CN¥1.13 Billion | CN¥600.75 Million | ▼ -21.3% |
| 2020 | 0.60x | CN¥712.69 Million | CN¥1.19 Billion | CN¥479.59 Million | ▼ -19.8% |
| 2019 | 0.75x | CN¥859.04 Million | CN¥1.15 Billion | CN¥293.13 Million | ▲ +529.5% |
| 2018 | 0.12x | CN¥103.87 Million | CN¥876.94 Million | CN¥773.07 Million | ▼ -85.3% |
| 2017 | 0.81x | CN¥775.69 Million | CN¥961.19 Million | CN¥185.50 Million | ▲ +86.4% |
| 2016 | 0.43x | CN¥314.24 Million | CN¥725.76 Million | CN¥411.53 Million | ▲ +220.9% |
| 2015 | -0.36x | CN¥-105.51 Million | CN¥294.58 Million | CN¥400.09 Million | ▼ -173.9% |
| 2014 | 0.48x | CN¥99.81 Million | CN¥205.89 Million | CN¥106.08 Million | ▲ +249.1% |
| 2013 | 0.14x | CN¥30.70 Million | CN¥221.06 Million | CN¥190.36 Million | ▲ +156.8% |
| 2012 | -0.24x | CN¥-47.51 Million | CN¥194.32 Million | CN¥241.83 Million | ▼ -144.7% |
| 2010 | 0.55x | CN¥87.74 Million | CN¥160.40 Million | CN¥72.66 Million | ▲ +4.3% |
| 2009 | 0.52x | CN¥87.13 Million | CN¥166.20 Million | CN¥79.07 Million | ▲ +35.8% |
| 2008 | 0.39x | CN¥35.65 Million | CN¥92.31 Million | CN¥56.67 Million | ▲ +134.0% |
| 2007 | -1.14x | CN¥-137.39 Million | CN¥120.94 Million | CN¥258.34 Million | ▼ -39.2% |
| 2006 | -0.82x | CN¥-128.90 Million | CN¥158.00 Million | CN¥286.90 Million | ▼ -177.1% |
| 2005 | -0.29x | CN¥-27.15 Million | CN¥92.23 Million | CN¥119.38 Million | ▲ +89.2% |
| 2004 | -2.73x | CN¥-35.91 Million | CN¥13.17 Million | CN¥49.08 Million | ▼ -901.8% |
| 2003 | -0.27x | CN¥-12.39 Million | CN¥45.51 Million | CN¥57.90 Million | ▲ +84.8% |
| 2002 | -1.79x | CN¥-57.42 Million | CN¥31.99 Million | CN¥89.41 Million | ▼ -827.6% |
| 2001 | 0.25x | CN¥29.04 Million | CN¥117.73 Million | CN¥88.69 Million | ▲ +130.8% |
| 2000 | -0.80x | CN¥-23.34 Million | CN¥29.12 Million | CN¥52.46 Million | — |